STRM.BIO INCORPORATED
CAMBRIDGE, MA 02139-3544
Visibility Score
32
Capabilities Narrative
STRM.BIO is developing cell-based nanoparticles (exosomes) that naturally home to and fuse with hematopoietic stem cells (HSCs) in the bone marrow to deliver gene therapies.
NAICS Codes
| Code | Description | Primary |
|---|---|---|
| 541713 | Research and Development in Nanotechnology | |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) |
Keywords
cell based, nanoparticles, exosomes, extracellular vesicles, hematopoietic stem cells, bone marrow, gene delivery, gene therapy
Contact Information
Business Details
- UEI
- L64LC4L45N55
- CAGE Code
- 8J2B6
- Year Established
- 2019
- Legal Structure
- Corporation
- Congressional District
- 07